How Yograj and Kaishore Guggulu differ in ingredients and positioning, and what to specify when ordering either in bulk.
Yograj Guggulu and Kaishore Guggulu are both classical multi-herb guggulu formulations from the Ayurvedic tradition, but their ingredient profiles reflect different classical indications and target different product positioning. Brand owners choosing between them for private-label development should understand how ingredient composition shapes category fit and regulatory documentation requirements.
Yograj Guggulu is described in the Sharangdhar Samhita and other classical texts as a formulation combining Shuddha Guggulu with a range of herbs, typically including Ajamoda, Yavani, Kala Jeera, Saindhava Lavana and several others as specified in the Ayurvedic Formulary of India. It belongs to the Guggulu category of formulations prepared by incorporating powdered herbs into a purified resin base.
Kaishore Guggulu, referenced in the Sharangdhar Samhita and Bhaishajya Ratnavali, contains Triphala (Haritaki, Bibhitaki, Amalaki), Guduchi, Trikatu, Danti, Trivrit, Guggulu and other ingredients as specified in the AFI. The formulation belongs to the same Guggulu category but has a distinct herb composition. Both are classical Shastrayoga formulations, meaning composition is fixed by the source text rather than being proprietary, and any manufacturer using the classical name must follow the relevant AFI monograph exactly. This fixed composition simplifies regulatory documentation because the formulation is defined by an official reference rather than a proprietary recipe.
| Feature | Yograj Guggulu | Kaishore Guggulu |
|---|---|---|
| Primary herbs | Ajamoda, Yavani and other Vata-pacifying herbs | Triphala, Guduchi, Trikatu, Danti, Trivrit |
| Classical text basis | Sharangdhar Samhita (Guggulu Kalpana) | Sharangdhar Samhita, Bhaishajya Ratnavali |
| Approximate ingredient count | 27 to 30 per AFI | 14 to 16 per AFI |
| Guggulu base | Shuddha Guggulu | Shuddha Guggulu |
| AFI monograph available | Yes, Part I | Yes, Part I |
Note: exact ingredient counts may vary between editions of the AFI. Always refer to the current edition for specification.
A formulation with 27 or more ingredients requires sourcing, identification testing and quality release of each raw material individually before it enters the batch. Each additional ingredient adds to the incoming quality control burden, batch manufacturing time and the risk of one ingredient failing specification and placing the entire batch on hold. Yograj Guggulu's higher ingredient count makes raw material traceability more demanding.
For a brand owner, this translates into longer lead times for complex multi-herb batches and a higher per-unit cost relative to simpler formulations. When requesting a quotation from a contract manufacturer, specify which edition of the AFI your formulation should comply with and ask whether all ingredient identification certificates will accompany the batch record.
Understanding cost drivers helps you budget accurately rather than comparing headline prices across suppliers who may be using different sourcing standards for individual botanicals. A low quoted price may reflect lower-grade ingredients or fewer incoming quality tests, not a more efficient process.
It also matters whether the manufacturer holds all required herbs in-house. A facility that routinely produces Yograj Guggulu will have its approved supplier network in place for all 27 to 30 ingredients, reducing sourcing delays compared to a facility that makes the formulation only occasionally and must locate some botanicals to order each time.
Neither formulation may be described as treating, curing or preventing any disease in B2B marketing or labelling. Both sit within the traditional Ayurvedic category of Guggulu preparations broadly associated with musculoskeletal applications.
Yograj Guggulu is traditionally associated in classical texts with Vata imbalances affecting the musculoskeletal system. Kaishore Guggulu is traditionally associated with Pitta-related conditions and appears in classical texts in contexts involving metabolic imbalance and inflammatory presentations. For B2B product positioning, the key question is which traditional category your distribution channel supports and which classical indication appears in your target market's Ayurvedic regulatory framework.
Export buyers should confirm that the chosen formulation has a monograph in the current AFI and that the ingredient list matches what the importing country's regulatory authority will accept under its traditional medicine product category. Some importing markets accept formulations by AFI reference number; others require full ingredient disclosure with botanical names and sourcing documentation. Checking this before finalising your product selection avoids having to reformulate or rename after submission.
Several practical factors guide the choice. Distribution channel alignment: some distributors specialise in Vata-related joint health product lines; others focus on broader musculoskeletal health or detox-positioning ranges. The classical indication profile of each formulation should match the channel's existing product documentation and buyer expectations.
Regulatory documentation: both formulations have AFI monographs, which simplifies documentation for import clearance in many jurisdictions. Confirm with your regulatory consultant which specific edition and ingredient list your target country requires before placing an order.
Formulation complexity and minimum production run: Yograj Guggulu's larger ingredient list may affect the minimum batch size that is economically viable for the manufacturer. Ask how ingredient complexity affects scheduling and whether the facility holds all ingredients in-house.
Consistency of raw material supply: both require high-quality Shuddha Guggulu as the base. Ask specifically how the guggulu is sourced, tested and documented before use in formulation, since the quality of the resin base affects every batch. A documented guggulu sourcing policy at the manufacturer, covering approved origins and incoming test requirements, is a sign of a facility that takes raw material quality seriously across all its formulations.
Raasa Ayurveda's Guggulu category covers sixteen classical formulations including both Yograj and Kaishore Guggulu, manufactured in Kanpur under GMP certificate D-5755/09. For sourcing enquiries, comparison of sample batches or bulk supply discussions, contact raasaayurveda@gmail.com or call +91 9415128217.
No. Neither Yograj Guggulu nor any Ayurvedic formulation should be labelled with a claim to treat, cure or prevent any disease in most regulatory frameworks. B2B positioning should reference classical traditional use and the relevant AFI monograph. Consult a regulatory expert for your specific destination market's labelling rules.
Yes. Both formulations are listed in the Ayurvedic Formulary of India, which fixes the ingredient list and proportions. A manufacturer producing either formulation under the classical name must follow the AFI specification. Always confirm which edition of the AFI applies and request the batch record to verify ingredient compliance.
Kaishore Guggulu typically has a lower ingredient count than Yograj Guggulu, which can make raw material sourcing and incoming quality control somewhat simpler. However, manufacturing ease depends on a facility's existing approved supplier network and botanical stock. Discuss both options with your contract manufacturer before committing.
Provide the exact formulation name, the AFI edition you are referencing, the target dosage form (tablet or pill), quantity in kilograms or number of units, packaging requirement and destination market. This allows the manufacturer to price accurately against the correct specification rather than making assumptions about ingredient grade or batch size.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.